Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-27 @ 1:32 PM
Study NCT ID:
NCT00741260
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2008-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer
Sponsor:
Puma Biotechnology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3144A1-2206 / B1891017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None